Establishing cut-off values for mild, moderate and severe disease in patients with pemphigus using the Pemphigus Disease Area Index

Br J Dermatol. 2021 May;184(5):975-977. doi: 10.1111/bjd.19718. Epub 2021 Feb 1.

Authors

R L Krain^{1

2}, C E Bax^{1

2}, S Chakka^{1

2}, S Ahmed^{1

2}, R Feng³, A S Payne², V P Werth^{1

2}

Affiliations

¹ Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
² Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA.
³ Department of, Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, USA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural

MeSH terms

Desmoglein 1
Desmoglein 3
Humans
Pemphigus* / diagnosis
Severity of Illness Index

Substances

Desmoglein 1
Desmoglein 3

Grants and funding

TL1 TR001880/TR/NCATS NIH HHS/United States